Abstract
BackgroundTreatment with naturally occurring antitumor T cells, or cells genetically modified to express their receptors (TCRs), has shown efficacy in patients with advanced malignancies.1–3 Previous studies have demonstrated success in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
